image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Spire Healthcare - Remgro acquires Cinven stake for 360p-a-share

August 2015

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SPI
  • Price:
  • 340p
The shares bounced after Remgro, the major shareholder of South-African-based private hospital operator, Mediclinic, acquired a 29.9% stake from Cinven at 360p a share. Cinven, a perceived overhang on the shares, now has just 8.4%.Quoted on the Johannesburg Stock Exchange, Mediclinic operates 70 hospitals and specialist care facilities in Southern Africa, Switzerland and the UAE and generated sales of £1.8bn and profits of £293m in the year to March 2015. While it has no “current” intention to bid for Spire it is only restricted from making one for the next six months.Attracting such an illustrious partner is a tremendous coup for Spire and with the pro healthcare privatisation Conservatives winning th ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe